BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11850829)

  • 1. Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome.
    Lui WO; Chen J; Gläsker S; Bender BU; Madura C; Khoo SK; Kort E; Larsson C; Neumann HP; Teh BT
    Oncogene; 2002 Feb; 21(7):1117-22. PubMed ID: 11850829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
    Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
    Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
    N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1-0.2 Mb bacterial artificial chromosome array spanning chromosome arm 1p.
    Aarts M; Dannenberg H; deLeeuw RJ; van Nederveen FH; Verhofstad AA; Lenders JW; Dinjens WN; Speel EJ; Lam WL; de Krijger RR
    Genes Chromosomes Cancer; 2006 Jan; 45(1):83-93. PubMed ID: 16215979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
    Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
    Richard S; Martin S; David P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pheochromocytoma, first manifestation of Von Hippel-Lindau disease: a possibility to be considered].
    Richard S; Resche F; Vermesse B; Fendler JP; Francillard M; Laroche F; Luton JP; Méry JP; Proye C; Redondo A
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1153-6. PubMed ID: 1482250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
    Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma.
    Zeiger MA; Zbar B; Keiser H; Linehan WM; Gnarra JR
    Genes Chromosomes Cancer; 1995 Jul; 13(3):151-6. PubMed ID: 7669733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization.
    Sprenger SH; Gijtenbeek JM; Wesseling P; Sciot R; van Calenbergh F; Lammens M; Jeuken JW
    J Neurooncol; 2001 May; 52(3):241-7. PubMed ID: 11519854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray-based comparative genomic hybridization of pheochromocytoma cell lines from neurofibromatosis knockout mice reveals genetic alterations similar to those in human pheochromocytomas.
    Powers JF; Tischler AS; Mohammed M; Naeem R
    Cancer Genet Cytogenet; 2005 May; 159(1):27-31. PubMed ID: 15860353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene and growth factor expression in MEN 2 and related tumors.
    Moley JF; Wallin GK; Brother MB; Kim M; Wells SA; Brodeur GM
    Henry Ford Hosp Med J; 1992; 40(3-4):284-8. PubMed ID: 1362425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pheochromocytoma and Von Hippel-Lindau in pregnancy.
    Kolomeyevskaya N; Blazo M; Van den Veyver I; Strehlow S; Aagaard-Tillery KM
    Am J Perinatol; 2010 Mar; 27(3):257-63. PubMed ID: 19784914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
    Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
    J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of a pediatric pheochromocytoma with suspected bilateral disease.
    Mircescu H; Wilkin F; Paquette J; Oligny LL; Decaluwe H; Gaboury L; Nolet S; Van Vliet G; Deal C
    J Pediatr; 2001 Feb; 138(2):269-73. PubMed ID: 11174629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.
    Pack SD; Zbar B; Pak E; Ault DO; Humphrey JS; Pham T; Hurley K; Weil RJ; Park WS; Kuzmin I; Stolle C; Glenn G; Liotta LA; Lerman MI; Klausner RD; Linehan WM; Zhuang Z
    Cancer Res; 1999 Nov; 59(21):5560-4. PubMed ID: 10554035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
    Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
    Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic genomic imbalances in pediatric pheochromocytoma.
    Hering A; Guratowska M; Bucsky P; Claussen U; Decker J; Ernst G; Hoeppner W; Michel S; Neumann H; Parlowsky T; Loncarevic I
    Genes Chromosomes Cancer; 2006 Jun; 45(6):602-7. PubMed ID: 16518846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
    Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM
    Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Huynh TT; Pacak K; Wong DL; Linehan WM; Goldstein DS; Elkahloun AG; Munson PJ; Eisenhofer G
    Ann N Y Acad Sci; 2006 Aug; 1073():241-52. PubMed ID: 17102092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.